252 related articles for article (PubMed ID: 16412109)
1. Onchocerciasis-associated limb swelling in a traveler returning from Cameroon.
Ezzedine K; Malvy D; Dhaussy I; Steels E; Castelein C; De Dobbeler G; Heenen M
J Travel Med; 2006; 13(1):50-3. PubMed ID: 16412109
[TBL] [Abstract][Full Text] [Related]
2. [Apropos of 5 new cases of onchocerciasis edema].
Nozais JP; Caumes E; Datry A; Bricaire F; Danis M; Gentilini M
Bull Soc Pathol Exot; 1997; 90(5):335-8. PubMed ID: 9507765
[TBL] [Abstract][Full Text] [Related]
3. Chemokines in onchocerciasis patients after a single dose of ivermectin.
Fendt J; Hamm DM; Banla M; Schulz-Key H; Wolf H; Helling-Giese G; Heuschkel C; Soboslay PT
Clin Exp Immunol; 2005 Nov; 142(2):318-26. PubMed ID: 16232219
[TBL] [Abstract][Full Text] [Related]
4. Impact of four years of large-scale ivermectin treatment with low therapeutic coverage on the transmission of Onchocerca volvulus in the Mbam valley focus, central Cameroon.
Pion SD; Clément MC; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Sep; 98(9):520-8. PubMed ID: 15251400
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic image (105). A woman with painful nodules. Infection with O. volvulus].
Kampinga GA; Sprenger HG; de Graeff PA; Rulo HF; de Vries-Hospers HG
Ned Tijdschr Geneeskd; 2002 Sep; 146(37):1734. PubMed ID: 12357874
[TBL] [Abstract][Full Text] [Related]
6. Effect of repeated treatments with ivermectin on the incidence of onchocerciasis in northern Cameroon.
Boussinesq M; Chippaux JP; Ernould JC; Quillevere D; Prod'hon J
Am J Trop Med Hyg; 1995 Jul; 53(1):63-7. PubMed ID: 7625535
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms.
Bourguinat C; Pion SD; Kamgno J; Gardon J; Gardon-Wendel N; Duke BO; Prichard RK; Boussinesq M
Parasitology; 2006 Feb; 132(Pt 2):255-62. PubMed ID: 16197589
[TBL] [Abstract][Full Text] [Related]
8. Onchocerciasis in New York City. The Moa-Manhattan connection.
Encarnacion CF; Giordano MF; Murray HW
Arch Intern Med; 1994 Aug; 154(15):1749-51. PubMed ID: 8042892
[TBL] [Abstract][Full Text] [Related]
9. Onchocerciasis in a teenager from Africa.
Leake JA; Pong AL; Scher CA; Newbury RO; Cunningham BB
Arch Dermatol; 2004 Sep; 140(9):1161-6. PubMed ID: 15381564
[No Abstract] [Full Text] [Related]
10. Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly.
Kamgno J; Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Duke BO; Boussinesq M
Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):496-504. PubMed ID: 15186939
[TBL] [Abstract][Full Text] [Related]
11. Onchocerca volvulus breast mass: case report from Cameroon and literature review.
Zavieh K; McCarthur C; Eswaran SL; DePond W
Mo Med; 2004; 101(6):608-10. PubMed ID: 15679004
[TBL] [Abstract][Full Text] [Related]
12. Recent updates on onchocerciasis: diagnosis and treatment.
Udall DN
Clin Infect Dis; 2007 Jan; 44(1):53-60. PubMed ID: 17143815
[TBL] [Abstract][Full Text] [Related]
13. Relationship between oral declaration on adherence to ivermectin treatment and parasitological indicators of onchocerciasis in an area of persistent transmission despite a decade of mass drug administration in Cameroon.
Wanji S; Kengne-Ouafo JA; Esum ME; Chounna PW; Adzemye BF; Eyong JE; Jato I; Datchoua-Poutcheu FR; Abong RA; Enyong P; Taylor DW
Parasit Vectors; 2015 Dec; 8():667. PubMed ID: 26715524
[TBL] [Abstract][Full Text] [Related]
14. Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination.
Duerr HP; Raddatz G; Eichner M
Int J Parasitol; 2011 Apr; 41(5):581-9. PubMed ID: 21255577
[TBL] [Abstract][Full Text] [Related]
15. Onchocerciasis in a nonendemic population: clinical and immunologic assessment before treatment and at the time of presumed cure.
Henry NL; Law M; Nutman TB; Klion AD
J Infect Dis; 2001 Feb; 183(3):512-6. PubMed ID: 11133386
[TBL] [Abstract][Full Text] [Related]
16. [An itching disease from the tropics: onchocerciasis as an imported disease].
de Vries PJ; Kingma WP; Wetsteyn JC
Ned Tijdschr Geneeskd; 1994 Sep; 138(36):1793-8. PubMed ID: 7935904
[No Abstract] [Full Text] [Related]
17. Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.
Duke BO
Parasitology; 2005 Apr; 130(Pt 4):447-53. PubMed ID: 15830819
[TBL] [Abstract][Full Text] [Related]
18. [Onchocerciasis in travelers to the tropics].
Junghanss T; Weiss N
Dtsch Med Wochenschr; 1990 Sep; 115(37):1392-6. PubMed ID: 2401191
[TBL] [Abstract][Full Text] [Related]
19. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
20. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues.
Katabarwa M; Eyamba A; Habomugisha P; Lakwo T; Ekobo S; Kamgno J; Kuete T; Ndyomugyenyi R; Onapa A; Salifou M; Ntep M; Richards FO
Trop Med Int Health; 2008 Sep; 13(9):1196-203. PubMed ID: 18631308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
